drugset / Trial / NCT03690622

Effect of Topical Dexmedetomidine on Intraocular Pressure

NCT03690622 ↗

Phase 4 Completed 49 enrolled Beirut Eye Specialist Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluate the short-term safety and efficacy of dexmedetomidine (0.0055%) drops on intraocular pressure (IOP) in healthy eyes.

Timeline

Start
2017-12-01
Primary completion
2018-01-01
Completion
2018-04-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.0055 % Topical

Indications